Botanical species · safety record

Pinus mugo

The EFSA Compendium of Botanicals holds 1 constituent measurement and 1 adverse-effect record for Pinus mugo. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Pinus mugo Turra

1Constituent measurements
1Safety records
2Cited sources
8Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 8 licensed products naming Pinus mugo as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Bud
  • Buds
  • Needle oil

What the records describe

Constituents measured

  • Indole-3-acetic acid1

Plant parts

  • Leaves1
  • Unspecified1

Preparations

  • Essential oil (as part-nature)1

Effect types

  • Digestive1

Target tissues

  • Digestive1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Indole-3-acetic acidLeavesFluorimetry, Nephelometry and PolarimetryResolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestiveUnspecifiedEssential oil (as part-nature)Human (as organism)Case reportResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Vitalone, A., Menniti-Ippolito, F., Raschetti, R., Renda, F., Tartaglia, L., Mazzanti, G. Surveillance of suspected adverse reactions to herbal products used as laxatives. European journal of clinical pharmacology, 2012, vol. 68, no. 3, p. 231-238. DOI
  2. PSOTA, V., KLICOVA, S., KRALIK, J. CHANGES IN THE CONTENT OF INDOLE-3-ACETIC-ACID IN THE NEEDLES OF DWARF PINE IN THE COURSE OF YEAR . Biologia plantarum, 1995, vol. 37, no. 3, p. 453-455. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue